BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33342723)

  • 1. Role of the vulnerable elders survey-13 screening tool in predicting treatment plan modification for older adults with cancer.
    Almugbel FA; Timilshina N; AlQurini N; Loucks A; Jin R; Berger A; Romanovsky L; Puts M; Alibhai SMH
    J Geriatr Oncol; 2021 Jun; 12(5):786-792. PubMed ID: 33342723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the Vulnerable Elders Survey 13 screening tool in identifying cancer treatment modification after geriatric assessment in pre-treatment patients: A retrospective analysis.
    Rowbottom L; Loucks A; Jin R; Breunis H; Syed AT; Watt S; Timilshina N; Puts M; Yokom D; Berger A; Alibhai SMH
    J Geriatr Oncol; 2019 Mar; 10(2):229-234. PubMed ID: 30420323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer.
    Shah M; Noronha V; Ramaswamy A; Gattani S; Mokal S; Joshi A; Patil V; Menon N; Banavali S; Badwe R; Prabhash K
    J Geriatr Oncol; 2022 Jun; 13(5):720-730. PubMed ID: 35283049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation.
    Mohile SG; Bylow K; Dale W; Dignam J; Martin K; Petrylak DP; Stadler WM; Rodin M
    Cancer; 2007 Feb; 109(4):802-10. PubMed ID: 17219443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geriatric oncology screening tools for CGA-based interventions: results from a phase II study of geriatric assessment and management for older adults with cancer.
    Yokom DW; Alibhai SMH; Sattar S; Krzyzanowska MK; Puts MTE
    J Geriatr Oncol; 2018 Nov; 9(6):683-686. PubMed ID: 29540293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gait Speed vs. VES-13: A Pilot Study Comparing Screening Tools to Determine the Need for a Comprehensive Geriatric Assessment in Senior Women with Breast Cancer.
    Hollenberg DC; Menjak IB; Mehta R; Bristow B; Trudeau ME; Gibson L; Neve M; Norris M; Pasetka M; Rice K; McCullock F; Wright FC; Szumacher E
    J Med Imaging Radiat Sci; 2019 Dec; 50(4):551-556. PubMed ID: 31780434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two frailty screening tools in older women with early breast cancer.
    Molina-Garrido MJ; Guillen-Ponce C
    Crit Rev Oncol Hematol; 2011 Jul; 79(1):51-64. PubMed ID: 20663685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The linear relationship between the Vulnerable Elders Survey-13 score and mortality in an Asian population of community-dwelling older persons.
    Wang J; Lin W; Chang LH
    Arch Gerontol Geriatr; 2018 Jan; 74():32-38. PubMed ID: 28957686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vulnerable Elderly Survey 13 as a screening method for frailty in Polish elderly surgical patient--prospective study.
    Kenig J; Richter P; Zychiewicz B; Olszewska U
    Pol Przegl Chir; 2014 Mar; 86(3):126-31. PubMed ID: 24791815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?
    Biganzoli L; Boni L; Becheri D; Zafarana E; Biagioni C; Cappadona S; Bianchini E; Oakman C; Magnolfi SU; Di Leo A; Mottino G
    Ann Oncol; 2013 Feb; 24(2):494-500. PubMed ID: 23045516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of VES-13 questionnaires in the Senior Women's Breast Cancer Clinic at Sunnybrook Health Sciences, Toronto, Ontario, Canada.
    Zereshkian A; Khan BM; Cao X; Henry-Noel N; Menjak I; Mehta R; Bristow B; Trudeau M; Neve M; Norris M; Pasetka M; Rice K; McCullock F; Wright F; Szumacher E
    J Geriatr Oncol; 2022 May; 13(4):541-544. PubMed ID: 35125335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13).
    Luciani A; Biganzoli L; Colloca G; Falci C; Castagneto B; Floriani I; Battisti N; Dottorini L; Ferrari D; Fiduccia P; Zafarana E; Del Monte F; Galli F; Monfardini S; Foa P
    J Geriatr Oncol; 2015 Jul; 6(4):272-9. PubMed ID: 26088748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying an accurate pre-screening tool in geriatric oncology.
    Kellen E; Bulens P; Deckx L; Schouten H; Van Dijk M; Verdonck I; Buntinx F
    Crit Rev Oncol Hematol; 2010 Sep; 75(3):243-8. PubMed ID: 20060313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13.
    Luciani A; Ascione G; Bertuzzi C; Marussi D; Codecà C; Di Maria G; Caldiera SE; Floriani I; Zonato S; Ferrari D; Foa P
    J Clin Oncol; 2010 Apr; 28(12):2046-50. PubMed ID: 20308657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer.
    Cavdar E; Iriagac Y; Karaboyun K; Avci O; Seber ES
    J Geriatr Oncol; 2022 Jul; 13(6):821-827. PubMed ID: 35361561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Frailty in Older Patients With Early-Stage Solid Tumors: A Prospective Longitudinal Evaluation of Three Different Geriatric Tools.
    Biganzoli L; Mislang AR; Di Donato S; Becheri D; Biagioni C; Vitale S; Sanna G; Zafarana E; Gabellini S; Del Monte F; Mori E; Pozzessere D; Brunello A; Luciani A; Laera L; Boni L; Di Leo A; Mottino G
    J Gerontol A Biol Sci Med Sci; 2017 Jul; 72(7):922-928. PubMed ID: 28158486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening older cancer patients for a Comprehensive Geriatric Assessment: A comparison of three instruments.
    Owusu C; Koroukian SM; Schluchter M; Bakaki P; Berger NA
    J Geriatr Oncol; 2011 Apr; 2(2):121-129. PubMed ID: 21927633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy - The randomized NORDIC9-study.
    Liposits G; Ryg J; Skuladottir H; Winther SB; Möller S; Hofsli E; Shah CH; Poulsen LØ; Berglund Å; Qvortrup C; Osterlund P; Glimelius B; Sorbye H; Pfeiffer P
    J Geriatr Oncol; 2023 Jan; 14(1):101408. PubMed ID: 36494261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Geriatric Assessment in Men Aged 70 Years or Older with Localised Prostate Cancer Undergoing Radical Radiotherapy.
    Osborne GEC; Appleyard SA; Gilbert DC; Jones CI; Lorimer C; Villanueva M; Peasgood E; Robinson A; Nikapota A; Ring A
    Clin Oncol (R Coll Radiol); 2017 Sep; 29(9):609-616. PubMed ID: 28592379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.
    Soubeyran P; Bellera C; Goyard J; Heitz D; Curé H; Rousselot H; Albrand G; Servent V; Jean OS; van Praagh I; Kurtz JE; Périn S; Verhaeghe JL; Terret C; Desauw C; Girre V; Mertens C; Mathoulin-Pélissier S; Rainfray M
    PLoS One; 2014; 9(12):e115060. PubMed ID: 25503576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.